Core Viewpoint - The stock of United Imaging Healthcare (688271) experienced a slight decline of 1.4% on January 27, 2026, closing at 132.08 yuan, with a trading volume of 78,700 hands and a total transaction amount of 1.046 billion yuan [1]. Group 1: Financial Performance - For the first three quarters of 2025, United Imaging Healthcare reported a main revenue of 8.859 billion yuan, representing a year-on-year increase of 27.39% [2]. - The net profit attributable to shareholders reached 1.12 billion yuan, up 66.91% year-on-year, while the net profit excluding non-recurring items was 1.053 billion yuan, reflecting a significant increase of 126.94% [2]. - In Q3 2025, the company achieved a single-quarter main revenue of 2.843 billion yuan, marking a 75.41% year-on-year growth, and a net profit of 122 million yuan, which is a 143.8% increase year-on-year [2]. - The company's debt ratio stands at 30.08%, with investment income of 606.847 million yuan and financial expenses of -438.233 million yuan, while the gross profit margin is 47.02% [2]. Group 2: Market Sentiment and Ratings - Over the past 90 days, 24 institutions have provided ratings for United Imaging Healthcare, with 17 giving a "buy" rating and 7 an "accumulate" rating [2]. - The average target price set by institutions in the last 90 days is 17.635 billion yuan [2]. Group 3: Capital Flow - On January 27, 2026, the net outflow of main funds was 33.918 million yuan, accounting for 3.24% of the total transaction amount, while retail investors saw a net inflow of 9.547 million yuan, representing 0.91% of the total transaction amount [1].
股票行情快报:联影医疗(688271)1月27日主力资金净卖出3391.81万元